[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334530-105":59,"doc-detail-334530-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","investigating-the-association-between-genetically-proxied-circulating-levels-of-immune-checkpoint-proteins-and-cancer-survival-protocol-for-a-mendelian-randomisation-analysis","Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival - protocol for a Mendelian randomisation analysis","","Compared with traditional drug development, drug repurposing can reduce time, cost and resources. Immune checkpoint inhibitors are used for several cancers by targeting immune checkpoint proteins that suppress T-cell activation. Because T-cell suppression is common across cancer sites, this protocol tests whether genetically proxied targets of two inhibitors (PD-1 and PD-L1) are associated with survival across seven cancer types. Two-sample Mendelian randomisation will use European-ancestry genome-wide data, with sensitivity, collider and instrument-construction analyses, plus assessment of treatment history and tumour stage when available.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigating-the-association-between-genetically-proxied-circulating-levels-of-immune-checkpoint-proteins-and-cancer-survival-protocol-for-a-mendelian-randomisation-analysis/334530/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigating-the-association-between-genetically-proxied-circulating-levels-of-immune-checkpoint-proteins-and-cancer-survival-protocol-for-a-mendelian-randomisation-analysis/334530.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the protocol address?","Question",{"text":112,"@type":113},"It investigates whether genetically proxied circulating levels of immune checkpoint proteins targeted by PD-1 and PD-L1 are associated with cancer survival across seven cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which analytic approach will be used?",{"text":117,"@type":113},"A two-sample Mendelian randomisation framework will leverage summary genetic association data from separate samples to estimate effects on survival.",{"name":119,"@type":110,"acceptedAnswer":120},"How will the study evaluate robustness and potential biases?",{"text":121,"@type":113},"It will conduct sensitivity analyses to test robustness to violations of Mendelian randomisation assumptions, collider bias, and alternative genetic instrument construction strategies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334530,1791167213,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Open access Protocol  \n Investigating the association between  \ngenetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis  \nTessa Bate  ,1,2 Richard M Martin,1,2,3 James Yarmolinsky,1,2,4 Philip C Haycock1,2  \nTo cite: Bate T, Martin RM, Yarmolinsky J, et al. Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol fora Mendelian randomisation analysis. BMJ Open 2024;14:e075981 . doi:10 . 1136/ bmjopen-2023-075981  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([http://dx.doi.org/10.1136/](http://dx.doi.org/10.1136/)[ ](http://dx.doi.org/10.1136/)[bmjopen-2023-075981](bmjopen-2023-075981)) .  \nJY and PCH contributed equally.  \nReceived 24 May 2023 Accepted 23 October 2023  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. For numbered affiliations see end of article.  \nCorrespondence to  \nDr Philip C Haycock;  \n[philip.haycock@bristol.ac.uk](philip.haycock@bristol.ac.uk)  \nABSTRACT  \nIntroduction Compared with the traditional drug development pathway, investigating alternative uses for existing drugs (ie, drug repurposing) requires substantially less time, cost and resources. Immune checkpoint inhibitors are licensed for the treatment of certain breast, colorectal, head and neck, lung and melanoma cancers. These drugs target immune checkpoint proteins to reduce the suppression of T cell activation by cancer cells. As T cell suppression is a hallmark of cancer common across anatomical sites, we hypothesise that immune checkpoint inhibitors could be repurposed for the treatment of additional cancers beyond the ones already indicated. Methods and analysis We will use two-sample Mendelian randomisation to investigate the effect of genetically proxied levels of protein targets of two immune checkpoint inhibitors—programmed cell death protein 1 and programmed death ligand 1—on survival of seven cancer types (breast, colorectal, head and neck, lung, melanoma, ovarian and prostate). Summary genetic association data will be obtained from prior genome-wide association studies of circulating protein levels and cancer survival in populations of European ancestry. Various sensitivity analyses will be performed to examine the robustness of findings to potential violations of Mendelian randomisation assumptions, collider bias and the impact of alternative genetic instrument construction strategies. The impact of treatment history and tumour stage on the findings will also be investigated using summary-level and individual-level genetic data where available.  \nEthics and dissemination No separate ethics approval will be required for these analyses as we will be using data from previously published genome-wide association studies which individually gained ethical approval and participant consent. Results from analyses will be submitted as an open-access peer-reviewed publication and statistical code will be made freely available on the completion of the analysis.  \nINTRODUCTION  \nDrug repurposing is the use of approved drugs for another indication.1 2 The traditional development and testing pathway of candidate drugs is expensive and time-consuming,  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ As germline genetic variants proxying circulating protein levels are randomly assorted at meiosis and fixed at conception, Mendelian randomisation analyses examining the effect of these proteins on cancer survival should be less prone to conventional issues of confounding and cannot be influenced by reverse causation bias.  \n⇒ The use of a two-sample Mendelian randomisation framework will permit us to leverage large-scale genetic association data from separate samples, thus enhancing statistical power and precision of estimates.  \n⇒ The generalisabili","cbCaikxjKo7Gwt6Q","https://ap.wps.com/l/cbCaikxjKo7Gwt6Q","pdf",374615,"English","# ABSTRACT\n# INTRODUCTION\n# STRENGTHS AND LIMITATIONS OF THIS STUDY","[{\"question\":\"What question does the protocol address?\",\"answer\":\"It investigates whether genetically proxied circulating levels of immune checkpoint proteins targeted by PD-1 and PD-L1 are associated with cancer survival across seven cancer types.\"},{\"question\":\"Which analytic approach will be used?\",\"answer\":\"A two-sample Mendelian randomisation framework will leverage summary genetic association data from separate samples to estimate effects on survival.\"},{\"question\":\"How will the study evaluate robustness and potential biases?\",\"answer\":\"It will conduct sensitivity analyses to test robustness to violations of Mendelian randomisation assumptions, collider bias, and alternative genetic instrument construction strategies.\"}]","Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival - protocol for a Mendelian randomisation analysis | PDF",1790007084,25]